ES526275A0 - Procedimiento de preparacion de nuevas 2-amino 5-aminometil 2-oxazolinas - Google Patents

Procedimiento de preparacion de nuevas 2-amino 5-aminometil 2-oxazolinas

Info

Publication number
ES526275A0
ES526275A0 ES526275A ES526275A ES526275A0 ES 526275 A0 ES526275 A0 ES 526275A0 ES 526275 A ES526275 A ES 526275A ES 526275 A ES526275 A ES 526275A ES 526275 A0 ES526275 A0 ES 526275A0
Authority
ES
Spain
Prior art keywords
aminometil
oxazolines
amino
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526275A
Other languages
English (en)
Other versions
ES8405777A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8216782A external-priority patent/FR2533922A1/fr
Priority claimed from FR8308477A external-priority patent/FR2546167B2/fr
Application filed by Cortial SA filed Critical Cortial SA
Publication of ES8405777A1 publication Critical patent/ES8405777A1/es
Publication of ES526275A0 publication Critical patent/ES526275A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES526275A 1982-10-05 1983-10-05 Procedimiento de preparacion de nuevas 2-amino 5-aminometil 2-oxazolinas Granted ES526275A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8216782A FR2533922A1 (fr) 1982-10-05 1982-10-05 Nouvelles amino-2 aminomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique
FR8308477A FR2546167B2 (fr) 1983-05-19 1983-05-19 Nouvelles amino-2 piperazino et piperidinomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique

Publications (2)

Publication Number Publication Date
ES8405777A1 ES8405777A1 (es) 1984-06-16
ES526275A0 true ES526275A0 (es) 1984-06-16

Family

ID=26223093

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526275A Granted ES526275A0 (es) 1982-10-05 1983-10-05 Procedimiento de preparacion de nuevas 2-amino 5-aminometil 2-oxazolinas

Country Status (8)

Country Link
US (1) US4497812A (es)
EP (1) EP0106776B1 (es)
JP (1) JPH0647580B2 (es)
CA (1) CA1217485A (es)
DE (1) DE3367098D1 (es)
ES (1) ES526275A0 (es)
OA (1) OA07555A (es)
PT (1) PT77428B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912120A (en) * 1986-03-14 1990-03-27 Syntex (U.S.A.) Inc. 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
US4929630A (en) * 1986-03-14 1990-05-29 Syntex (U.S.A.) Inc. Transglutaminase inhibitors
FR2645860B1 (fr) * 1989-04-14 1991-07-26 Sarget Lab Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques
EP1030849A1 (en) 1997-11-12 2000-08-30 The Pennsylvania State University Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands
US6476233B1 (en) 1998-11-12 2002-11-05 The Penn State Research Foundation Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands and related compounds
MX2009008465A (es) * 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
AU2014241065B2 (en) * 2013-03-14 2017-08-31 Merck Patent Gmbh Glycosidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445581A1 (de) * 1960-10-13 1969-06-04 Albert Ag Chem Werke N-[5-Methyloxazolinyl-(2)]-N'-aryl-Harnstoffderivate und Verfahren zu deren Herstellung
FR2448M (fr) * 1963-02-27 1964-04-06 Mcneilab Inc Composé de la classe des 2-amino-5-aryl-oxazolines et compositions pharmaceutiques le contenant.
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3930008A (en) * 1972-10-16 1975-12-30 Luso Farmaco Inst 4-Aryl-5-aminoalkyl-4-oxazolin-2-ones

Also Published As

Publication number Publication date
ES8405777A1 (es) 1984-06-16
JPS5988475A (ja) 1984-05-22
PT77428B (fr) 1986-02-27
EP0106776B1 (fr) 1986-10-22
DE3367098D1 (en) 1986-11-27
US4497812A (en) 1985-02-05
OA07555A (fr) 1985-03-31
CA1217485A (fr) 1987-02-03
JPH0647580B2 (ja) 1994-06-22
EP0106776A1 (fr) 1984-04-25
PT77428A (fr) 1983-10-01

Similar Documents

Publication Publication Date Title
MX6387E (es) Procedimiento para la preparacion de n-(heterocicloaminocarbonil)arilsulfonamidas
RO90861A (ro) Procedeu pentru prepararea etielnglicolului
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
RO86213A (ro) Procedeu pentru prepararea izobutenei
MX5375E (es) Procedimiento para la preparacion de n-(diaminofosfinil)-arilcarboxamidas
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
ES501488A0 (es) Procedimiento para la preparacion de aclaradores bis-estil- benicos
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
AR229356A1 (es) Procedimiento para la preparacion de n-(clorometil)acilaminas
ES538117A0 (es) Procedimiento para la preparacion de compuestos triglicidilicos de aminofenoles
RO88128A (ro) Procedeu pentru prepararea n-fosfanometilglicinei
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
ES526275A0 (es) Procedimiento de preparacion de nuevas 2-amino 5-aminometil 2-oxazolinas
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
ES533017A0 (es) Procedimiento para la obtencion de oxazolidinonas trisustituidas
MX6900E (es) Procedimiento para la preparacion de n-(halogenometil)acilamidas
DK296383A (da) Fremgangsmaade til fremstilling af fenaetylaminer
AR223553A1 (es) Procedimiento para la preparacion de n-(4-anilinofenil)metaclilamida
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK9383A (da) Fremgangsmaade til fremstilling af phosphinoxider
IT1193383B (it) Procedimento per la dealogenazione di eteri

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20041102